The United States gene therapy market size was valued at USD 1,312.2 Million in 2024. It is forecasted to reach USD 3,697.8 Million by 2033, exhibiting a CAGR of 12.1% for the period 2025–2033. Key growth drivers include increasing prevalence of genetic disorders, rapid genetic engineeri